Key result
Permanent anticoagulation is required for HCM patients following incident AF regardless of CHA2DS2-VASc score.
Why the study?
This article aims to evaluate the current scientific evidence and treatment approaches for atrial fibrillation in patients diagnosed with hypertrophic cardiomyopathy.
Permanent anticoagulation is required in HCM patients with AF regardless of CHA2DS2-VASc score, and atrial cardiomyopathy independently increases thromboembolic risk.
Requires anticoagulation after first AF in HCM regardless of CHA2DS2-VASc; extends evidence for atrial myopathy as independent thromboembolic risk factor.
Hypertrophic cardiomyopathy (HCM) is the most common genetic disease in the general population, with a variable phenotypic expression and symptomatology. Atrial fibrillation (AF) is the most common arrhythmia identified among patients diagnosed with HCM. Treatment of both AF and HCM has continuously evolved over time, leading to a significant improvement in the prognosis and life expectancy of symptomatic patients. Numerous studies have demonstrated that the risk of developing this arrhythmia correlates with atrial morphological, functional and electrical remodeling, a process known as atrial myopathy. Once a first episode of AF is diagnosed, permanent anticoagulation is required among patients diagnosed with HCM, regardless of the CHA2 DS2-VA score. Additionally, atrial cardiomyopathy is associated with an increased thromboembolic risk, independent of AF presence, in patients with stable sinus rhythm, in the context of atrial mechanical and endothelial dysfunction. This article aims to evaluate the current scientific evidence and treatment approaches in patients diagnosed with HCM.
No takes yet. Share an insight, caveat, or question.
Angelescu et al. (2026) conducted a review in Hypertrophic Obstructive Cardiomyopathy and Atrial Fibrillation. Permanent anticoagulation is required for patients with hypertrophic cardiomyopathy following a first episode of atrial fibrillation, regardless of the CHA2DS2-VASc score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: